ECKERT & ZIEGLER SE (EUZ.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:EUZ - DE0005659700 - Common Stock
EUZ.DE Key Statistics, Chart & Performance
The current stock price of EUZ.DE is 15.62 EUR. In the past month the price decreased by -4.45%. In the past year, price decreased by -32.84%.
EUZ.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.74 | 116.09B | ||
| 1MDT.MI | MEDTRONIC PLC | 18.45 | 114.28B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 17.85 | 48.13B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.37 | 23.33B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.36 | 23.31B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.22 | 23.11B | ||
| BIM.PA | BIOMERIEUX | 27.9 | 12.75B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 151.44 | 4.55B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 25.16 | 3.85B | ||
| DIA.MI | DIASORIN SPA | 18.49 | 3.42B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.69 | 1.29B | ||
| DRW8.DE | DRAEGERWERK AG | 9.52 | 1.15B |
Related stock screener links
About EUZ.DE
Company Profile
Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. The company is headquartered in Berlin, Berlin and currently employs 1,098 full-time employees. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Company Info
ECKERT & ZIEGLER SE
Robert-Roessle-Str.10
Berlin BERLIN DE
Employees: 1085
Phone: 49309410840
ECKERT & ZIEGLER SE / EUZ.DE FAQ
What does EUZ do?
Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. The company is headquartered in Berlin, Berlin and currently employs 1,098 full-time employees. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
What is the current price of EUZ stock?
The current stock price of EUZ.DE is 15.62 EUR. The price decreased by -1.7% in the last trading session.
What is the dividend status of ECKERT & ZIEGLER SE?
ECKERT & ZIEGLER SE (EUZ.DE) has a dividend yield of 1.03%. The yearly dividend amount is currently 0.02.
What is the ChartMill technical and fundamental rating of EUZ stock?
EUZ.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What is ECKERT & ZIEGLER SE worth?
ECKERT & ZIEGLER SE (EUZ.DE) has a market capitalization of 992.18M EUR. This makes EUZ.DE a Small Cap stock.
When does ECKERT & ZIEGLER SE (EUZ.DE) report earnings?
ECKERT & ZIEGLER SE (EUZ.DE) will report earnings on 2026-03-26.
EUZ.DE Technical Analysis
EUZ.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to EUZ.DE. EUZ.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
EUZ.DE Financial Highlights
Over the last trailing twelve months EUZ.DE reported a non-GAAP Earnings per Share(EPS) of 0.65. The EPS increased by 43.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.06% | ||
| ROA | 8.79% | ||
| ROE | 17.17% | ||
| Debt/Equity | 0.16 |
EUZ.DE Forecast & Estimates
7 analysts have analysed EUZ.DE and the average price target is 22.92 EUR. This implies a price increase of 46.71% is expected in the next year compared to the current price of 15.62.
For the next year, analysts expect an EPS growth of 30.07% and a revenue growth 8.76% for EUZ.DE